Rede Mater Dei de Saúde (MATD3) posted net income of R$ 52.5 million in the third quarter of 2026 (3Q26), up 90.9% from 3Q25 and 16.6% from 2Q26. The net margin reached 7.9%, an increase of 3.1 percentage points year over year. The company attributes the result to growth in EBITDA (earnings before interest, taxes, depreciation and amortization) and lower financial expenses. Adjusted net income was R$ 52 million, up 50.5% from R$ 35 million in 3Q25, with an adjusted net margin of 7.9% (+1.8 percentage point).
Net revenue totaled R$ 660.2 million, up 16.3% from 3Q25 and 7.6% from 2Q26, and gross revenue was R$ 739.5 million (+16.0% vs. 3Q25). The company reports record quarterly net revenue and EBITDA. The average ticket reached R$ 3.06 million per bed, up 14.6% from 3Q25. Per patient-day, the average ticket was R$ 8,355, with 88,511 patient-days and an occupancy rate of 77.7% (83.8% including day hospital patients).
Adjusted EBITDA was R$ 148.2 million, an increase of 17.8% from 3Q25 and 7.0% from 2Q26. The EBITDA margin was 22.5%, compared with 22.2% in 3Q25. Gross profit totaled R$ 209.1 million (+22.2% from 3Q25), with a gross margin of 31.7%. The cost of services provided represented 68.3% of net revenue, a decrease of 1.6 percentage point from 3Q25.
Net financial result was negative R$ 41.7 million, a 24.9% reduction in net expense compared with 3Q25. The company cites the early redemption of R$ 200 million of the 3rd debenture issuance, the lower average Selic rate and the decline in the cost of debt.
Net debt closed the quarter at R$ 731 million, a reduction of R$ 32.5 million (4.3%) from 2Q26. The net debt/EBITDA ratio for the last 12 months stood at 1.4x, compared with 1.8x in 3Q25 and 1.5x in 2Q26. Cash totaled R$ 416 million, and the average cost of debt is CDI minus 0.98% per year, with an average amortization term of 4.7 years. In the nine months of 2026, net income was R$ 130.0 million (R$ 133.7 million adjusted) and net revenue totaled R$ 1.8 billion, up 14.6%.
